Panteli Theocharous | Chief Therapeutics & Clinical Strategy Officer (CTCSO) and President of Europe
Worldwide Clinical Trials

Panteli Theocharous, Chief Therapeutics & Clinical Strategy Officer (CTCSO)  and President of Europe, Worldwide Clinical Trials

I am Chief Therapeutics & Clinical Strategy Officer and President of Europe at Worldwide Clinical Trials, where I lead enterprise therapeutic and clinical strategy, strengthen the company’s scientific positioning, and support the development and delivery of complex, globally integrated clinical programmes. I bring more than 35-years of experience across academic institutions, private and public biotechnology companies, pharmaceutical organisations and global CROs. My career spans the full development continuum, from translational research, biomarkers and first-in-human studies through global clinical development, regulatory approval, HTA engagement, lifecycle management, capital formation and commercial execution.

Appearances:



Day 1 @ 16:10

Panel: Investor and Multistakeholder insights: What makes a Rare Trial De-Risked Globally?

last published: 12/Aug/26 16:45 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2026

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.